Infectiology

Quofenix®

Quofenix® is a broad-spectrum fluoroquinolone antibiotic.1

Quofenix® (delafloxacin) is an antibiotic from the fluoroquinolone group that is approved for the treatment of acute bacterial skin and skin structure infections (ABSSSI*) and community-acquired pneumonia (CAP**) in adults as monotherapy. In addition to its very broad spectrum of activity, both in the gram-negative and the gram-positive spectrum (incl. MRSA)1, the unique anionic structure of delafloxacin gives it increased intracellular penetration and enhanced bactericidal activity under acidic conditions that characterize the environment at a number of infection sites.2,3

With respect to known side effects from the class of fluoroquinolones, Quofenix® has a favorable tolerability profile because, unlike other fluoroquinolones, it shows no evidence of QT time prolongation or phototoxicity.4 Quofenix® is available as both an i.v. formulation and a tablet, allowing for optimal patient management.

* ABSSSI = acute bacterial skin and skin structure infections, ** CAP = community-acquired pneumonia

References: 1 Drug information, 2 Jorgensen SCJ, et al. lnfect Dis Ther. 2018;7(2):197-217, 3 Lemaire S, et al. Antimicrob Agents Chemother. 2011;55(2):649-658, 4 Lodise T. et al., Open Forum lnfect Dis 2018; 5(10)

AT-WEB-17-10-2021

menarini-austria-quofenix


Quofenix® is available in the following package sizes and dosages:
10 tablets - 450 mg (1)
10 vials - 300 mg (2)



Dear visitor, the gender form selected on our homepage always refers to female, male and various people at the same time. We have refrained from using a gender-specific spelling or multiple designations solely for the purpose of better readability. All personal designations are to be understood as gender-neutral.

Liebe Besucherin, lieber Besucher, die auf unserer Homepage gewählte Geschlechtsform bezieht sich immer zugleich auf weibliche, männliche und diverse Personen. Wir haben ausschließlich zum Zweck der besseren Lesbarkeit auf eine geschlechtsspezifische Schreibweise bzw. auf eine Mehrfachbezeichnung verzichtet. Alle personenbezogenen Bezeichnungen sind geschlechtsneutral zu verstehen.